Marc Andre Bigard

Summary

Affiliation: CHU de Nancy
Country: France

Publications

  1. ncbi request reprint Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg
    M A Bigard
    Gastroenterology Unit, University Hospital, Nancy, France
    Aliment Pharmacol Ther 22:635-43. 2005
  2. pmc Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial
    Denis Pouchain
    Département de médecine générale, Universite Francois Rabelais, Faculte de Medecine, 10 boulevard Tonnelle, BP 3223, 6 Rue du Docteur Lebel 94300, Vincennes 37032, Tours Cedex 1, France
    BMC Gastroenterol 12:18. 2012
  3. pmc Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China
    Min Chen
    INSERM, U724, Laboratory of Cellular and Molecular Pathology in Nutrition, Faculty of Medicine, Nancy Universite, Nancy Vandoeuvre, France
    BMC Med Genet 9:78. 2008
  4. ncbi request reprint [Esophageal complications of non steroidal antiinflammatory drugs]
    Marc Andre Bigard
    Service d Hepato Gastroenterologie, CHU de Nancy Brabois, Vandoeuvre les Nancy
    Gastroenterol Clin Biol 28:C58-61. 2004
  5. ncbi request reprint [Therapeutic innovations in gastroesophageal reflux]
    Marc Andre Bigard
    Service d Hepatogastroenterologie, Hopital de Brabois, Vandoeuvre les Nancy, France
    Presse Med 36:1907-12. 2007
  6. doi request reprint Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn's disease
    Vincent Billioud
    Inserm U954, Université Henri Poincaré 1, Vandoeuvre les Nancy, France
    Dig Liver Dis 44:466-70. 2012
  7. doi request reprint Submucosal plexitis as a predictor of postoperative surgical recurrence in Crohn's disease
    Aude Bressenot
    Inserm U954, Genetic Nutrition and Exposure to Environmental Risks NGERE, Henri Poincare University, Vandoeuvre les Nancy, France
    Inflamm Bowel Dis 19:1654-61. 2013
  8. doi request reprint Urinary tract infections in hospitalized inflammatory bowel disease patients: a 10-year experience
    Laurent Peyrin-Biroulet
    INSERM, U954 and Department of Hepato Gastroenterology, University Hospital of Nancy, Vandoeuvre les Nancy, France
    Inflamm Bowel Dis 18:697-702. 2012
  9. doi request reprint A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization
    Abderrahim Oussalah
    INSERM, U954 and Department of Hepato Gastroenterology, University Hospital of Nancy, Vandoeuvre les Nancy, France
    Am J Gastroenterol 105:2617-25. 2010
  10. doi request reprint Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
    Laurent Peyrin-Biroulet
    Department of Hepato Gastroenterology, University Hospital of Nancy Brabois, Vandoeuvre les Nancy, France
    Gut 60:930-6. 2011

Collaborators

Detail Information

Publications27

  1. ncbi request reprint Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg
    M A Bigard
    Gastroenterology Unit, University Hospital, Nancy, France
    Aliment Pharmacol Ther 22:635-43. 2005
    ..Relapse is frequent after initial treatment for gastro-oesophageal reflux. An alternative strategy to intermittent or continuous therapy may be on-demand treatment...
  2. pmc Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial
    Denis Pouchain
    Département de médecine générale, Universite Francois Rabelais, Faculte de Medecine, 10 boulevard Tonnelle, BP 3223, 6 Rue du Docteur Lebel 94300, Vincennes 37032, Tours Cedex 1, France
    BMC Gastroenterol 12:18. 2012
    ..Alginates also have proven efficacy. The aim of this trial was to compare short-term efficacy of an alginate (Gaviscon®, 4 × 10 mL/day) and omeprazole (20 mg/day) on GERD symptoms in general practice...
  3. pmc Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China
    Min Chen
    INSERM, U724, Laboratory of Cellular and Molecular Pathology in Nutrition, Faculty of Medicine, Nancy Universite, Nancy Vandoeuvre, France
    BMC Med Genet 9:78. 2008
    ..We evaluated the association of the polymorphisms of MTHFR, MTR, MTRR and TCN2 genes with ulcerative colitis in Central China...
  4. ncbi request reprint [Esophageal complications of non steroidal antiinflammatory drugs]
    Marc Andre Bigard
    Service d Hepato Gastroenterologie, CHU de Nancy Brabois, Vandoeuvre les Nancy
    Gastroenterol Clin Biol 28:C58-61. 2004
    ..NSAIDs can provoke a pill-induced esophagitis, specially if the drugs are absorbed without water and in case of preexistant acid reflux...
  5. ncbi request reprint [Therapeutic innovations in gastroesophageal reflux]
    Marc Andre Bigard
    Service d Hepatogastroenterologie, Hopital de Brabois, Vandoeuvre les Nancy, France
    Presse Med 36:1907-12. 2007
    ..Endoscopic methods developed in recent years have not been shown effective in trials versus sham procedures. Surgical treatment is effective in GER but causes frequent uncomfortable side effects that are difficult to treat...
  6. doi request reprint Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn's disease
    Vincent Billioud
    Inserm U954, Université Henri Poincaré 1, Vandoeuvre les Nancy, France
    Dig Liver Dis 44:466-70. 2012
    ..No definite conclusions can be drawn from available data on the accuracy of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to assess disease activity in Crohn's disease...
  7. doi request reprint Submucosal plexitis as a predictor of postoperative surgical recurrence in Crohn's disease
    Aude Bressenot
    Inserm U954, Genetic Nutrition and Exposure to Environmental Risks NGERE, Henri Poincare University, Vandoeuvre les Nancy, France
    Inflamm Bowel Dis 19:1654-61. 2013
    ..We assessed the value of both submucosal and myenteric plexitis for predicting postoperative surgical recurrence in CD...
  8. doi request reprint Urinary tract infections in hospitalized inflammatory bowel disease patients: a 10-year experience
    Laurent Peyrin-Biroulet
    INSERM, U954 and Department of Hepato Gastroenterology, University Hospital of Nancy, Vandoeuvre les Nancy, France
    Inflamm Bowel Dis 18:697-702. 2012
    ..Cystitis is the most common genitourinary complication in Crohn's disease (CD). We assessed the prevalence of and risk factors for urinary tract infections (UTI) in inflammatory bowel diseases (IBD)...
  9. doi request reprint A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization
    Abderrahim Oussalah
    INSERM, U954 and Department of Hepato Gastroenterology, University Hospital of Nancy, Vandoeuvre les Nancy, France
    Am J Gastroenterol 105:2617-25. 2010
    ..The objective of this study was to evaluate short- and long-term outcomes of infliximab in ulcerative colitis (UC), including infliximab optimization, colectomy, and hospitalization...
  10. doi request reprint Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
    Laurent Peyrin-Biroulet
    Department of Hepato Gastroenterology, University Hospital of Nancy Brabois, Vandoeuvre les Nancy, France
    Gut 60:930-6. 2011
    ..The aim of the study was to assess whether azathioprine and antitumour necrosis factor (TNF) treatment decrease the long-term need for surgery in patients with Crohn's disease...
  11. doi request reprint Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases
    Arthur Belle
    aInserm U954 and Department of Hepato Gastroenterology, University Hospital of Nancy bESPRI Unit, Clinical Epidemiology, CHU de Nancy, Lorraine University, Vandoeuvre les Nancy, France
    Eur J Gastroenterol Hepatol 27:877-81. 2015
    ..We compared the efficacy of HBV vaccine between IBD patients and healthy controls and investigated the impact of immunosuppressive therapy on vaccine response in IBD patients...
  12. doi request reprint The extra burden of infliximab infusions in inflammatory bowel disease
    Anthony Buisson
    Department of Hepato Gastroenterology, University Hospital Estaing of Clermont Ferrand, Universite d Auvergne, Clermont Ferrand, France Microbes, Intestine, inflammation and susceptibility of the host, UMR Inserm Université d Auvergne, U1071, USC INRA 2018, Clermont Universite, Clermont Ferrand, France and Inserm U954 and Department of Hepato Gastroenterology, University Hospital of Nancy, Université HenriPoincaré 1, Vandoeuvre les Nancy, France
    Inflamm Bowel Dis 19:2464-7. 2013
    ..The median duration of each hospitalization stay, including time for infusion and the cost for the health care system, are unknown. We assessed the extra burden of IFX infusions in inflammatory bowel disease (IBD)...
  13. doi request reprint Tolerability of one hour 10mg/kg infliximab infusions in inflammatory bowel diseases: a prospective multicenter cohort study
    Abdenour Babouri
    Inserm U954, Department of Hepato Gastroenterology, University Hospital of Nancy, Université Henri Poincaré 1, Vandoeuvre les Nancy, France
    J Crohns Colitis 8:161-5. 2014
    ..A retrospective study with small sample size demonstrated the feasibility of 1-hour infusion time for 10mg/kg infliximab in IBD patients...
  14. doi request reprint Colonoscopic perforations in inflammatory bowel disease: a retrospective study in a French referral centre
    Anthony Buisson
    Department of Hepato Gastroenterology, University Hospital Estaing of Clermont Ferrand, Universite d Auvergne, Clermont Ferrand, France
    Dig Liver Dis 45:569-72. 2013
    ..Whether inflammatory bowel disease patients are at increased risk of colonoscopic perforations remains controversial. Aim of this study was to investigate whether these patients are at increased risk of perforations...
  15. doi request reprint Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease
    Abderrahim Oussalah
    INSERM, U954 and Department of Hepato Gastroenterology, University Hospital of Nancy, Vandoeuvre les Nancy, France
    Gut 59:1056-65. 2010
    ..We evaluated the accuracy of MRI in combination with diffusion-weighted imaging (DWI-MRI) without oral or rectal preparation in assessing colonic inflammation in both ulcerative colitis and Crohn's disease...
  16. doi request reprint Adherence to adalimumab therapy in Crohn's disease: a French multicenter experience
    Vincent Billioud
    INSERM, U954 and Department of Hepato Gastroenterology, University Hospital of Nancy, Vandoeuvre les Nancy, France
    Inflamm Bowel Dis 17:152-9. 2011
    ..We evaluated adherence to adalimumab therapy in Crohn's disease (CD)...
  17. doi request reprint Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West Africa
    Jean Pierre Bronowicki
    INSERM U724, Cellular and Molecular Pathology in Nutrition, Faculte de Medecine, University Henri Poincaré of Nancy, Vandoeuvre les Nancy, France
    J Hepatol 48:532-9. 2008
    ..We evaluated the association of determinants of homocysteine metabolism with the outcome of HBV infection...
  18. ncbi request reprint Association of MTRR 66A>G polymorphism with superoxide dismutase and disease activity in patients with Crohn's disease
    Laurent Peyrin-Biroulet
    INSERM, U724, Laboratory of Cellular and Molecular Pathology in Nutrition, Faculty of Medicine, Vandoeuvre les Nancy, France
    Am J Gastroenterol 103:399-406. 2008
    ..The aim of this study was to evaluate the association of nutritional (folate, vitamin B12) and genetic (MTHFR, MTR, MTRR, TCN) determinants of homocysteine metabolism and of superoxide dismutase with Crohn's disease (CD)...
  19. doi request reprint Self-insertion of a nasogastric tube for home enteral nutrition: a pilot study
    Didier Quilliot
    Department of Nutrition, Nancy University Hospital, Vandoeuvre les Nancy, France Inserm U954, Medical Faculty and CHU of Nancy, Vandoeuvre les Nancy, France
    JPEN J Parenter Enteral Nutr 38:895-900. 2014
    ..Enteral tube feeding can be a source of discomfort and reluctance from patients. We evaluated for the first time the tolerability of self-insertion of a nasogastric (NG) tube for home enteral nutrition (EN)...
  20. doi request reprint Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience
    Estelle Freling
    Department of Dermatology and Allergy, University Hospital of Nancy, Lorraine University, Vandoeuvre les Nancy, France
    Am J Gastroenterol 110:1186-96. 2015
    ..We assessed the cumulative incidence of anti-TNF-induced cutaneous adverse reactions in IBD patients, their risk factors, their dermatological management, and their outcome in a large cohort of IBD patients...
  21. ncbi request reprint [Pancreatic pseudocysts of the right hepatic lobe during acute biliary pancreatitis]
    David Ancel
    Service d Hepato Gastroenterologie, CHU Brabois, 54500 Vandoeuvre les Nancy, France
    Gastroenterol Clin Biol 29:743-5. 2005
    ..We suggest another reason for hepatic invasion: pancreatic enzymes could also cause liver damage, through the para - renal anterior space, often infiltrated during acute pancreatitis, reaching right hepatic lobe through area nuda...
  22. doi request reprint Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel disease
    Véronique Cloché
    Department of Ophthalmology, Nancy University Hospital, Vandoeuvre les Nancy, France
    Dig Liver Dis 45:195-9. 2013
    ..Ocular manifestations are frequent in patients with inflammatory bowel disease...
  23. doi request reprint Tolerability of one hour 10 mg/kg infliximab infusions in patients with inflammatory bowel disease
    Abdenour Babouri
    INSERM, U954 and Department of Hepato Gastroenterology, University Hospital of Nancy, Université Henri Poincaré 1, Vandoeuvre les Nancy, France
    J Crohns Colitis 7:129-33. 2013
    ..The tolerability of one 1-hour 10 mg/kg infliximab infusion in patients with IBD is unknown...
  24. doi request reprint Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy
    Abderrahim Oussalah
    INSERM, U954 and Department of Hepato Gastroenterology, University Hospital of Nancy, Vandoeuvre les Nancy, France
    Am J Gastroenterol 105:1142-9. 2010
    ..Whether all Crohn's disease (CD) patients should maintain long-term azathioprine treatment in combination with infliximab remains controversial. We analyzed the predictive factors of infliximab failure after azathioprine withdrawal...
  25. doi request reprint Nonfistulizing perianal Crohn's disease: clinical features, epidemiology, and treatment
    Guillaume Bouguen
    Department of Hepato Gastroenterology, University Hospital of Rennes, Pontchaillou, Vandoeuvre les Nancy, France
    Inflamm Bowel Dis 16:1431-42. 2010
    ..This review article may help physicians in decision-making when managing potentially disabling lesions...
  26. ncbi request reprint Defecation disorders: a French population survey
    Laurent Siproudhis
    Gastroenterology Unit, Centre Hospitalier Régionale and Universitaire de Pontchaillou, Rennes, France
    Dis Colon Rectum 49:219-27. 2006
    ..This study was designed to assess symptoms, lifestyle-behavioral changes, and medical care seeking related to functional defecation disorders in a large household community survey...
  27. ncbi request reprint [Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies]
    M A Bigard
    Service d Hepatogastroenterologie, CHU de Nancy Brabois, F54500 Vandoeuvre les Nancy
    Presse Med 30:1305-12. 2001
    ..pylori gastritis since a beneficial effect is achieved in only 5% of the treated patients. Systematic eradication in order to reduce the incidence of gastric adenocarcinoma is not recommended...